Bombay High Court has directed the Indian drug regulator National
Pharmaceutical Pricing Authority (NPPA) to examine if it can cap
per-year increase in N-95 masks at 10 per cent as per rules related to
essential drugs
Bombay High Court has directed the Indian drug regulator National
Pharmaceutical Pricing Authority (NPPA) to examine if it can cap
per-year increase in N-95 masks at 10 per cent as per rules related to
essential drugs